Texas Doctor Stephen M. Hahn is a top contender to head FDA

Wall Street Journal

4 September 2019 - M.D. Anderson’s radiation-oncology chief is among three leading candidates for post open since April.

Stephen M. Hahn, a senior executive and radiation oncologist at M.D. Anderson Cancer Center in Houston, has emerged as a leading candidate to be nominated by the Trump administration to become commissioner of the Food and Drug Administration, according to people familiar with the matter.

Dr. Hahn, 59 years old, is chief of radiation oncology and chief medical executive at M.D. Anderson, a research and clinical hospital affiliated with the University of Texas. He didn’t respond to phone calls or an email seeking comment. One person familiar with the events said Dr. Hahn now is the leading contender.

Read Wall Street Journal article

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Medicine , US , Regulation , Management